Occipital lobe seizures related to marked elevation of hemoglobin A1C: report of two cases.
Occipital lobe seizures caused by nonketotic hyperglycemia (NKH) have been reported in only a few cases and are not fully characterized. We report two cases of NKH-related occipital lobe seizures with high hemoglobin A1C (HbA1C), epileptiform electroencephalograph (EEG) and MRI abnormalities. Both patients had moderate hyperglycemia (310-372 mg/dl) and mildly elevated serum osmolarity (295-304 mOsm/kg) but markedly elevated HbA1C (13.8-14.4%). One patient had a clinico-EEG seizure originating from the right occipital region during sleep. The other patient had an interictal epileptiform discharge consisting of unilateral occipital beta activity in sleep. None of the previously reported cases fulfilled the criteria of a nonketotic hyperglycemic hyperosmolar (NKHH) state, or showed any interictal beta paroxysms, spikes, sharp waves, or spike/sharp-slow wave complexes. We suggest that prolonged exposure to uncontrolled hyperglycemia, as indicated by HbA1C, rather than an acute NKHH state is crucial in the development of this peculiar seizure. We also suggest clinicians look for the presence of interictal focal beta paroxysms in addition to the usual epileptiform discharges while reading the EEG of these patients.
Hung
Wan-Ling
WL
Division of Neurology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.
Hsieh
Peiyuan F
PF
Lee
Yi-Chung
YC
Chang
Ming-Hong
MH
D000138:Acidosis / Q000150:complications; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D004569:Electroencephalography; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006944:Hyperglycemic Hyperosmolar Nonketotic Coma / Q000097:blood / Q000150:complications / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009778:Occipital Lobe; D010672:Phenytoin / Q000627:therapeutic use; D012640:Seizures / Q000097:blood* / Q000503:physiopathology*
D000927:Anticonvulsants; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D010672:Phenytoin